Close

News

Revenue Clawback Rate Increase Warned By ABPI In The UK

The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue clawback rate increase for branded medications. The Department of Health and Social Care (DHSC) is now...

Endometrial Cancer Survival Is An Enhanced Possibility

A Phase III trial found that pembrolizumab plus chemotherapy enhanced survival in endometrial cancer patients. A Phase III clinical trial comparing pembrolizumab to chemotherapy (carboplatin and paclitaxel) enhanced progression-free survival (PFS) in patients with stage III-IV or recurrent endometrial cancer. As...

Regenerative Treatment For An Impaired Kidney Restoration

An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS), suggesting that regenerative treatment to restore damaged kidney function could be a sure possibility. In...

Fatty Liver Disease Gets A Novel Drug Healing Contender

Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease. There is presently no treatment for non-alcoholic fatty liver disease, which affects individuals with type 2 diabetes and can develop...

Clinical Trials Information System A Must In The EU Now

All initial clinical trial applications across the EU have to be submitted via the Clinical Trials Information System (CTIS) starting January 31, 2023. As per the European Medicines Agency (EMA), CTIS now happens to be the single-entry point for regulators...

Mechanism For Lung Adenocarcinoma Established By Researchers

Researchers have identified the mechanism that is responsible for the formation of cancer-associated fibroblasts, which happen to be essential for lung adenocarcinoma. Lung adenocarcinoma is the most frequent type of cancer of the lungs. It is related to cancer cells...

Singapore Witnesses A $50mn Funding In Research & Innovation

NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million, which will be transformational, from the Lee Foundation that will aid in providing support for the advancement of research and innovation via programmes as...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read